Pfizer-BioNTech COVID-19 Vaccine

Global Information About Pfizer‑BioNTech COVID‑19 Vaccine (also known as BNT162b2)

The approval status of the Pfizer‑BioNTech COVID‑19 Vaccine varies worldwide.For countries where the relevant regulatory authority has not authorised the vaccine or has not authorised it for an age group listed below, the vaccine is investigational and its safety and efficacy have not been established. Countries that have not authorised the vaccine will not be listed in the respective drop down below. 

As information may vary by country, please choose below in which country you are a licensed healthcare professional or recipient/caregiver to access more information on the Pfizer-BioNTech COVID-19 Vaccine.

Information about the Pfizer‑BioNTech COVID‑19 Vaccine is only available for certain countries. This site will be updated as more information becomes available.